Gevorg Yaghjyan/LinkedIn
Apr 9, 2026, 14:46
Gevorg Yaghjyan: Advancing Research and Care for Transketolase Deficiency at Yale
Gevorg Yaghjyan, Project Leader at Parexel, shared a post on LinkedIn:
”New rare-disease research and clinical program has recently been launched at the Yale School of Medicine focusing on Transketolase (TKT) deficiency, an extremely rare genetic metabolic disorder.
The Yale Transketolase Deficiency Program was established to:
- Improve diagnosis of patients with this rare disorder
- Conduct cutting-edge research on the disease mechanism
- Develop future therapeutic strategies
- Provide multidisciplinary clinical care for patients with suspected or confirmed disease
The program is led by physicians and researchers including Andrew Wang and Anna Szekely at Yale.
It collaborates with major rare-disease networks such as:
- the Undiagnosed Diseases Network
- the National Organization for Rare Disorders (NORD
to identify additional patients worldwide and accelerate research”
Stay updated with Hemostasis Today.
-
Apr 9, 2026, 14:31Maria Kousta: Global Collaboration Reveals New Insights on Stroke After AF Ablation
-
Apr 9, 2026, 14:28How One Patient’s Story Shows the Need for Fair Care – ASH
-
Apr 9, 2026, 14:26Augustina Isioma Ikusemoro: Transfusion Should Be Based on Clinical Need, Not Just Numbers
-
Apr 9, 2026, 14:20Julie Cardoso: Post-Thrombotic Syndrome – The Hidden Impact of DVT
-
Apr 9, 2026, 13:52Amlan Datta: When Do We Actually Use Dual Antiplatelet Therapy in Stroke Prevention?
-
Apr 9, 2026, 12:25Tara Lech: Key Pharmacotherapy Recommendations for Pulmonary Embolism
-
Apr 9, 2026, 12:18Sarah Sewaralthahab Joins the Editorial Board of Blood Global Hematology
-
Apr 9, 2026, 11:15Gopal Patidar: A Global Snapshot of Gaps in Transfusion Safety and Traceability
-
Apr 8, 2026, 18:14Simon Fletcher: The Unique Challenges PwH Face During Their Gene Therapy Journey